The city of Newport News, Virginia, currently has 1 active clinical trials seeking participants for Lung Cancer research studies.
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab
Recruiting
The primary objective of this study is to compare the efficacy of tarlatamab plus durvalumab with durvalumab alone on prolonging overall survival (OS).
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
01/22/2025
Locations: Virginia Oncology Associates, Newport News, Virginia
Conditions: Extensive-Stage Small-Cell Lung Cancer, Small-Cell Lung Cancer